Scheme 2
(E)-vinyl iodide 9 (Scheme 8), respectively. The key step in
our route involved the mercury-catalyzed Claisen rearrange-
ment of allyl-alcohol 15, itself accessible in five straight-
forward steps from 7. This should allow the stereoselective
introduction of the side chain at C10, which would be
ultimately one-carbon homologated to 19. Linking to the
coumarin could be subsequently performed at C11 by
converting the free hydroxyl functionality into a tosylate
leaving group followed by an ether formation.
Figure 1. Simplified schematic representation of Appendino’s and
Marner’s biogenetic proposals.
synthesis nor the ambiguity inherent in the structural revision8
has yet been addressed. Galbanic acid 1 bears structural
similarities with marneral 2,9 an alleged precursor of
triterpenoid iridals, themselves precursors of irones, which
suggests a common biogenetic origin. Marneral has been
suggested to derive from an acyclic precursor through a series
of cyclizations, 1,2-hydride, shifts and methyl migrations
(Figure 1),10 and one could assume a similar biosynthetic
sequence for the derivation of galbanic acid from umbelli-
prenin (5). The squalene to C10-epi marnerol sequence has
been successfully reproduced in a laboratory setting by
Marner and co-workers by using van Tamelen’s biomimetic
cyclization of 2,3-epoxysqualene,11 while Matsuda et al.12
have validated the Marner proposal that oxidosqualene
cyclizes en route to iridals via a B-ring boat intermediate to
marneral 2, providing the first experimental proof of a Grob
fragmentation in triterpene synthesis. On the other hand,
Appendino et al., while revising the structure of asacoumarin
B to galbanic acid, proposed a different biogenetic origin
for this compound,2a via a fragmentative, rather than a
cyclizative route, suggesting mogoltadone 6 as the biogenetic
precursor of galbanic acid (Figure 1).
Scheme 3
Elaboration of 7 began with the installation of the methyl
and ester groups at C9 using standard literature conditions
to afford 10 and its C-/O-biscarboxymethylated counterpart,
which was recycled by basic treatment (see Supporting
Information). After chromatographic separation, standard
reduction with LiAlH4 produced the primary-secondary diol
intermediates 11a and 11b in quantitative yield and 87:11
ratio, respectively. The major diol (11a) was protected as
its tert-butyldimethylsilyl ether 12 to be used in the allyl-
Claisen reaction (Scheme 3).
The stereochemistry of 11a was unequivocally established
by an X-ray crystallographic analysis (Figure 2). The one-
pot allyl-Claisen rearrangement conditions, reported by Dams
et al.13 on cis-pulegol derivatives, did not work with 12.
Instead, the stereoselective introduction of the side chain at
C10 has been cleanly achieved by first inducing the rear-
rangement of 11a in AcOH14 leading to 14 along with diene
13 (75% yield, 12:1 ratio, Scheme 3).
In this communication, we have developed a divergent
strategy to both galbanic acid and marneral, based on the
coupling of commercially available (R)-pulegone-derived
right halves 19 and 31 with umbelliferone 8 (Scheme 2) and
(8) The three stereogenic centres of galbanic acid are contiguous,
with the central one being tetrasubstituted. Within this structural context,
it is difficult to translate dipolar interactions into a configurational
assignment.
(9) Matsuda et al. (see ref 11) named this compound Marneral (and its
corresponding alcohol 33 Marnerol) in recognition of the pioneering work
of Marner on iridals. 2 has never been isolated but was hypothesized to be
the first carbocyclic precursor in the biosynthesis of iridals. (a) Marner,
F.-J.; Krick, W.; Gellrich, B.; Jaenicke, L.; Winter, W. J. Org. Chem. 1982,
47, 2531–2538. (b) Marner, F.-J. Curr. Org. Chem. 1997, 1, 153–186. (c)
Lamshoft, M.; Schmickler, H.; Marner, F.-J. Eur. J. Org. Chem. 2003, 727–
733.
(10) Marner, F.-J.; Longerich, I. Liebigs Ann. Chem. 1992, 269–272.
(11) (a) Marner, F.-J.; Kasel, T. J. Nat. Prod. 1995, 58, 319–323. (b)
Sharpless, K. B.; van Tamelen, E. E. J. Am. Chem. Soc. 1969, 91, 1848–
1849.
(13) CH3C(OEt)3, C2H5CO2H, H2O, 3 h at 138 °C: Dams, I.; Bialonska,
A.; Ciunik, Z.; Wawrzenczyk, C. Tetrahedron: Asymmetry 2005, 16, 2087–
2097.
(12) Xiong, Q.; Wilson, W. K.; Matsuda, S. P. T. Angew. Chem., Int.
Ed. 2006, 45, 1285–1288.
(14) Eschinasi, E. H. J. Org. Chem. 1970, 35, 2010–2012.
2854
Org. Lett., Vol. 10, No. 13, 2008